Literature DB >> 20381987

An interlaboratory study on the suitability of a gradient LC-UV method as a compendial method for the determination of erythromycin and its related substances.

L Van den Bossche1, A Lodi, J Schaar, S Shaakov, M Zorzan, M E Tranquillini, C Overballe-Petersen, J Hoogmartens, E Adams.   

Abstract

A liquid chromatographic (LC) method for the analysis of erythromycin and related substances has been adapted from an isocratic method developed by Chepkwony et al. (2001). The suitability of the method for general application as a compendial (pharmacopoeia) method has been assessed by means of an interlaboratory (collaborative) study. The method involves LC separation on a XTerra C18 column kept at 65 degrees C and UV detection at 210 nm. Five laboratories, located in Europe and the United States (US), participated in the study. Four erythromycin samples were tested. The main components (erythromycin A (EA), erythromycin B (EB), erythromycin C (EC)) and the impurities were determined. The analysis of variance was carried out on the results of the five laboratories to evaluate the between-laboratory consistencies and the laboratory-sample interaction. The estimates for the repeatability and reproducibility of the method, expressed as relative standard deviation (RSD) of the result of the determination of EA, were calculated to be 0.8% and 1.4% respectively. It is concluded that the method examined is a good replacement for the methods currently described in the European Pharmacopoeia (Ph. Eur.) and the United States Pharmacopoeia (USP), especially for its enhanced selectivity. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20381987     DOI: 10.1016/j.jpba.2010.03.012

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  2 in total

1.  First inter-laboratory comparison exercise for the determination of anticancer drugs in aqueous samples.

Authors:  Ester Heath; Marjeta Česen; Noelia Negreira; Miren Lopez de Alda; Laura Ferrando-Climent; Lucie Blahova; Tung Viet Nguyen; Mohamed Adahchour; Achim Ruebel; Neville Llewellyn; Janez Ščančar; Srdjan Novaković; Vesna Mislej; Marjeta Stražar; Damià Barceló; Tina Kosjek
Journal:  Environ Sci Pollut Res Int       Date:  2015-07-15       Impact factor: 4.223

2.  Erythromycin Modification That Improves Its Acidic Stability while Optimizing It for Local Drug Delivery.

Authors:  Erika L Cyphert; Jaqueline D Wallat; Jonathan K Pokorski; Horst A von Recum
Journal:  Antibiotics (Basel)       Date:  2017-04-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.